NPI: 1750532321 · CHEWELAH, WA 99109 · Critical Access Hospital · NPI assigned 10/01/2008
Authorized official ANDERSON, DONALD controls 20+ related entities in our dataset. Read more
| Authorized Official | ANDERSON, DONALD (ASSISTANT SECRETARY FOR ENROLLMENT) |
| NPI Enumeration Date | 10/01/2008 |
Other providers sharing the same authorized official: ANDERSON, DONALD
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 12,218 | $864K |
| 2019 | 9,940 | $682K |
| 2020 | 14,045 | $1.23M |
| 2021 | 18,574 | $1.69M |
| 2022 | 20,812 | $2.68M |
| 2023 | 19,703 | $2.00M |
| 2024 | 18,606 | $1.81M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 984 | 943 | $1.81M |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 4,420 | 3,265 | $1.66M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 5,437 | 4,199 | $1.34M |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 7,141 | 6,061 | $1.20M |
| 80053 | Comprehensive metabolic panel | 8,788 | 7,390 | $412K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 9,203 | 7,655 | $304K |
| 96361 | Intravenous infusion, hydration; each additional hour | 3,075 | 2,548 | $293K |
| 70450 | Computed tomography, head or brain; without contrast material | 636 | 608 | $286K |
| 96375 | Therapeutic injection; each additional sequential IV push | 2,645 | 2,214 | $280K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 2,027 | 1,353 | $272K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 4,643 | 1,843 | $248K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 6,419 | 2,495 | $228K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 2,311 | 2,084 | $179K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 2,931 | 2,455 | $172K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 1,706 | 1,615 | $136K |
| 71046 | Radiologic examination, chest; 2 views | 1,228 | 1,184 | $132K |
| 81001 | 4,561 | 4,204 | $115K | |
| 36415 | Collection of venous blood by venipuncture | 7,344 | 6,183 | $101K |
| 96376 | 762 | 584 | $98K | |
| 71045 | Radiologic examination, chest; single view | 1,420 | 1,302 | $97K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 721 | 676 | $86K |
| 83605 | 2,462 | 1,927 | $84K | |
| 84484 | 2,243 | 1,522 | $79K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1,221 | 987 | $78K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 1,180 | 588 | $75K |
| 83690 | 1,905 | 1,743 | $70K | |
| 87631 | 811 | 773 | $68K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 515 | 410 | $65K |
| 84443 | Thyroid stimulating hormone (TSH) | 1,568 | 1,524 | $60K |
| J7030 | Infusion, normal saline solution , 1000 cc | 1,825 | 1,529 | $53K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 2,037 | 1,745 | $52K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 619 | 595 | $52K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 42 | 37 | $52K |
| 82077 | 499 | 464 | $43K | |
| J1170 | Injection, hydromorphone, up to 4 mg | 998 | 737 | $40K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 1,840 | 1,764 | $39K |
| 80050 | General health panel | 252 | 248 | $39K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 160 | 122 | $35K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 370 | 350 | $32K |
| 81025 | 993 | 948 | $31K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 1,228 | 1,140 | $30K |
| 83735 | 1,654 | 1,307 | $27K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 189 | 177 | $27K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 194 | 188 | $25K |
| 72100 | 132 | 130 | $24K | |
| 83880 | 557 | 509 | $23K | |
| 80306 | 1,482 | 1,399 | $23K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 337 | 249 | $21K |
| J7050 | Infusion, normal saline solution, 250 cc | 1,179 | 486 | $19K |
| 85610 | 1,125 | 1,020 | $19K | |
| 73630 | 123 | 117 | $19K | |
| 80061 | Lipid panel | 456 | 447 | $15K |
| 87040 | 462 | 240 | $15K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 194 | 189 | $15K |
| 85379 | 295 | 283 | $12K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 104 | 96 | $11K |
| 86140 | 353 | 317 | $10K | |
| 73030 | 70 | 63 | $10K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 27 | 27 | $8K |
| 80048 | Basic metabolic panel (calcium, ionized) | 203 | 175 | $7K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 60 | 60 | $7K |
| 83036 | Hemoglobin; glycosylated (A1C) | 188 | 183 | $7K |
| 84439 | 207 | 202 | $7K | |
| 73562 | 40 | 40 | $6K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 318 | 146 | $6K |
| 85652 | 237 | 219 | $6K | |
| 87077 | 83 | 78 | $5K | |
| 97161 | 78 | 77 | $5K | |
| 73610 | 32 | 30 | $5K | |
| 82962 | 426 | 239 | $5K | |
| 82150 | 108 | 103 | $5K | |
| 80179 | 44 | 44 | $4K | |
| 80143 | 43 | 43 | $4K | |
| J7120 | Ringers lactate infusion, up to 1000 cc | 90 | 72 | $3K |
| 97162 | 38 | 36 | $3K | |
| 73130 | 18 | 14 | $2K | |
| 90715 | 13 | 12 | $2K | |
| 85027 | 87 | 75 | $2K | |
| 81003 | 150 | 142 | $2K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 86 | 82 | $2K |
| 87634 | 14 | 14 | $2K | |
| 73110 | 13 | 12 | $2K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 50 | 25 | $2K |
| 87400 | 24 | 12 | $1K | |
| 82607 | 27 | 26 | $1K | |
| 82805 | 25 | 24 | $1K | |
| 73502 | 12 | 12 | $1K | |
| 85730 | 65 | 65 | $1K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | 60 | 60 | $1K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 192 | 189 | $959.29 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 57 | 57 | $884.58 |
| 82746 | 14 | 13 | $742.05 | |
| 86803 | 13 | 13 | $643.15 | |
| 87205 | 27 | 24 | $610.28 | |
| 85651 | 25 | 25 | $531.48 | |
| J0780 | Injection, prochlorperazine, up to 10 mg | 16 | 12 | $530.06 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 85 | 70 | $480.72 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 27 | 24 | $480.25 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 27 | 26 | $394.26 |
| 94760 | 17 | 14 | $341.05 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 12 | 12 | $275.48 |
| A9270 | Non-covered item or service | 444 | 192 | $0.00 |